Cargando…
The efficacy of tolvaptan for heart failure in chronic kidney disease: A protocol for systematic review and meta-analysis
Approximately half of people with heart failure have chronic kidney disease (CKD). Tolvaptan is reported to be effective in treating heart failure. However, the safety and efficacy of its use in patients with CKD is uncertain. In this study, we conducted a protocol for systematic review and meta-ana...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803466/ https://www.ncbi.nlm.nih.gov/pubmed/36596041 http://dx.doi.org/10.1097/MD.0000000000032366 |